Aceragen, Inc. Quarterly Income Tax Expense (Benefit) in USD from Q1 2017 to Q1 2023
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Aceragen, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2017 to Q1 2023.
- Aceragen, Inc. Income Tax Expense (Benefit) for the quarter ending March 31, 2023 was -$273K.
- Aceragen, Inc. Income Tax Expense (Benefit) for the twelve months ending March 31, 2023 was -$6.59M, a 205% decline year-over-year.
- Aceragen, Inc. annual Income Tax Expense (Benefit) for 2022 was -$6.32M, a 200% decline from 2021.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)